(Q42060468)

15 October 2017

Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression (English)

1 reference

15 October 2017

Hashimoto Y

1

1 reference

15 October 2017

Kohri K

2

1 reference

15 October 2017

Kaneko Y

3

1 reference

15 October 2017

Morisaki H

4

1 reference

15 October 2017

Kato T

5

1 reference

15 October 2017

Ikeda K

6

1 reference

15 October 2017

Nakanishi M

7

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

Journal of Biological Chemistry

15 October 2017

1 reference

15 October 2017

273

1 reference

15 October 2017

16544-16550

1 reference

15 October 2017

26

1 reference

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

15 October 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Cell cycle. Dams and sluices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Cdk inhibitors: on the threshold of checkpoints and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Analysis of wild-type and mutant p21WAF-1 gene activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Cyclin-binding motifs are essential for the function of p21CIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

p21-containing cyclin kinases exist in both active and inactive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.26.16544

21 January 2018

Identifiers

DOI

10.1074/JBC.273.26.16544

1 reference

15 October 2017

1 reference